Home › Blood Cancers › New Jersey › Edison
Blood Cancers clinical trials in Edison, NJ
14 studies for Blood Cancers are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
RecruitingPhase 1
- Rutgers Cancer Institute of New Jersey, Piscataway · 2 mi away
Rutgers University Study of the Genetics of Blood Cancers
RecruitingObservational studyHealthy volunteers welcome
- Rutgers University, Piscataway · 2 mi away
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RecruitingPhase 2
- Astera Cancer Care ( Site 2732), East Brunswick · 6 mi away
Genomic Profiling in Cancer Patients
RecruitingObservational study
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RecruitingPhase 3
- Cancer Institute of New Jersey ( Site 0025), New Brunswick · 3 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Saint Peter's University Hospital, New Brunswick · 3 mi away
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi away
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
RecruitingPhase 1
- START New Jersey, East Brunswick · 6 mi away
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
RecruitingPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi away
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
RecruitingPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RecruitingHealthy volunteers welcome
- Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge · 15 mi away
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Rutgers Cancer Institute, New Brunswick · 3 mi away
Blood Cancers trials in other cities
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Seattle, WA18 studies
- Baltimore, MD18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Chicago, IL15 studies
- Philadelphia, PA14 studies
- Nashville, TN13 studies
- Columbus, OH13 studies
Other studies in Edison
- Breast Cancer69 studies
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)33 studies
- Prostate Cancer30 studies
- Lung Cancer24 studies
- Colorectal Cancer24 studies
- Bladder Cancer22 studies
- Multiple Myeloma22 studies
- Acute Myeloid Leukemia21 studies
- Endometrial Cancer20 studies
- Ovarian Cancer20 studies
- Metastatic Cancer18 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.